Breast Neoplasms: all 12,820 studies
Page 96 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.
- A Prospective Longitudinal Breast Cancer StudyCompletedNCT02270931
- Komen Breast Cancer Survivor Health Screening Promotion Project: Staying HealthyCompletedNCT02270580Not applicable
- Study of ONT-10 and Varlilumab to Treat Advanced Ovarian or Breast CancerCompletedNCT02270372Phase 1
- PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)CompletedNCT02269813
- The Effect of Metoprolol on Anaesthesia, the Need for Analgesics, and Pain in Breast Cancer PatientsWithdrawnNCT02269696Phase 3
- Redes II National Patient Navigator Intervention StudyCompletedNCT02269033Not applicable
- Ultrasound-based Breast Cancer Screening in Chinese WomenStatus unknownNCT02268643
- Intraoperative Radiation Therapy in Early Stage Breast CancerCompletedNCT02266602Not applicable
- Comparison of Biological Features Between pN0 Triple Negative Breast Tumours With Size < or = 10 mm (pT1a/b) Versus pT1c T2 < or = 30 mmCompletedNCT02266420Not applicable
- Observational Study of Pertuzumab Safety in Participants With Breast CancerCompletedNCT02266173
- Persistent Post-Surgical Pain in Women With BrCACompletedNCT02266082
- Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast CancerCompletedNCT02263846
- Dead Space Closure With Quilting Suture Versus Conventional Closure With DrainageCompletedNCT02263651Not applicable
- Eribulin Plus Gemcitabine (EG) vs Paclitaxel Plus Gemcitabine (PG) in HER2-Negative Metastatic Breast CancerCompletedNCT02263495Phase 2
- Follow-up of Early Breast Cancer by Dynamic Evaluation of CEA and CA 15.3 Followed by 18FDG-PETActive, not recruitingNCT02261389Not applicable
- Phase I, Dose Study to Look at the Safety and Pharmacokinetics of AZD8835 in Patients With Advanced Solid TumoursCompletedNCT02260661Phase 1
- Evolution of Resistance to Systemic Therapies in Patients With Breast CancerTerminatedNCT02257775
- Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) TrialCompletedNCT02256670Not applicable
- LEVEL UP: Video Games for Activity in Breast Cancer SurvivorsWithdrawnNCT02255240Not applicable
- Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast CancerTerminatedNCT02254031Phase 1
- Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast CancerCompletedNCT02254005Phase 1
- Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast CancerCompletedNCT02253459Phase 3
- Adaptated Physical Activity in CancerologyTerminatedNCT02252991Not applicable
- Intervention to Hepatic and Pulmonary Metastasis in Breast Cancer PatientsStatus unknownNCT02251353
- Intrapleural Bevacizumab After Pleural Drainage in the Context of Breast CancerTerminatedNCT02250118Phase 1
- Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.Status unknownNCT02249208Phase 3
- Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With BevacizumabCompletedNCT02248571Phase 4
- AZD9496 First Time in Patients Ascending Dose StudyCompletedNCT02248090Phase 1
- Patient-derived Xenograft (PDX) Modeling of Treatment Response for Triple Negative Breast CancerCompletedNCT02247037
- FAST MRI Study in Breast Cancer SurvivorsCompletedNCT02244593Not applicable
- Effect of Yoga on Life Quality and Immunity in Breast Cancer Patients After Operation and or ChemotherapyStatus unknownNCT02243163Not applicable
- Energy Balance and Breast Cancer Aspects-IIActive, not recruitingNCT02240836Not applicable
- Sentinel Node Biopsy in Breast Cancer: Omission of Axillary Clearance After Macrometastases. A Randomized Trial.Active, not recruitingNCT02240472Not applicable
- Study of Tumor RNA Disruption Assay™ (RDA)TerminatedNCT02239315Not applicable
- Safety and QoL of Trastuzumab With Lapatinib or Chemiotherapy in MBC and HER2+ Patients Refractory to Anti HER2 TherapiesStatus unknownNCT02238509Phase 2
- Prone Breast Radiotherapy Treatment Planning Observational StudyStatus unknownNCT02237469
- Cardiotoxicity Prevention in Breast Cancer Patients Treated With Anthracyclines and/or TrastuzumabStatus unknownNCT02236806Phase 3
- Exercise Intervention in Preventing Breast Cancer Recurrence in Postmenopausal Breast Cancer SurvivorsCompletedNCT02235051Not applicable
- Whole Breast RT on Prone Position in Korean WomenStatus unknownNCT02231112Phase 2
- Prevention of Paclitaxel Neuropathy With CryotherapyStatus unknownNCT02230319Phase 2
- Phase 2 Study of Standard Chemotherapy With Trastuzumab, Plus or Minus Pertuzumab, for Pre-treated Metastatic Breast CancerTerminatedNCT02229149Phase 2
- Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by EverolimusCompletedNCT02229136Phase 2
- Nurse-led Care Program for Cancer Patients in Chemotherapy Day CenterCompletedNCT02228200Not applicable
- Olaparib and Radiotherapy in Inoperable Breast CancerCompletedNCT02227082Phase 1
- ShearWave™ Elastography of Breast Lesions in Chinese PatientsCompletedNCT02226081
- A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.CompletedNCT02225652Phase 2
- Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and TaxanesCompletedNCT02225470Phase 3
- Cancer Prevention in Women With a BRCA MutationStatus unknownNCT02225015Phase 1
- Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesCompletedNCT02223052Phase 1
- Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer PatientsActive, not recruitingNCT02221999Phase 2/3
- Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast MalignanciesActive, not recruitingNCT02221700Not applicable
- Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by SurgeryCompletedNCT02219789Phase 1
- ForeCYTE Breast Aspirator for Sample Collection and Cytological Testing of Nipple Aspirate FluidCompletedNCT02218385
- Effects of 'R' (Electro-kinetic Beverage) on Insomnia, Fatigue, and Depression in Breast Cancer Patients Having Adjuvant ChemoTerminatedNCT02217033Not applicable
- A Randomized Study of AZD2014 in Combination With Fulvestrant in Metastatic or Advanced Breast CancerCompletedNCT02216786Phase 2
- PROACTIVE Study Evaluation of the Impact of a Multidimensional Geriatric Intervention ProgramCompletedNCT02216162Not applicable
- Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast CancerWithdrawnNCT02215876Phase 2
- A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low ResponseCompletedNCT02214381Phase 3
- Neoadjuvant Trastuzumab and Letrozole for Postmenopausal WomenStatus unknownNCT02214004Phase 2
- Intraoperative Radiotherapy for Korean Patients With Breast CancerStatus unknownNCT02213991Phase 2
- MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer PatientsTerminatedNCT02213744Phase 2/3
- Contrast-enhanced MR Imaging as a Breast Cancer Screening in Women at Intermediate RiskStatus unknownNCT02210546Not applicable
- Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).CompletedNCT02210364Phase 1
- The Symphony Triple A Study: Using Symphony in Treatment Decisions Concerning Adjuvant Systemic TherapyCompletedNCT02209857
- OctavaPink for Women With Dense Breast After Negative MammographyStatus unknownNCT02209389
- Digital 3D Breast Tomosynthesis Versus 2D in Clinical Evaluation of High Risk WomenStatus unknownNCT02209129
- mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and OvarianActive, not recruitingNCT02208375Phase 1
- Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast CancerStatus unknownNCT02207361Phase 4
- Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast CancerStatus unknownNCT02207335Phase 3
- Breast Cancer Margin Delineation Using Polarization Subtraction Imaging TechnologyStatus unknownNCT02207179Early Phase 1
- Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Breast Cancer, Non-small Cell Lung Cancer, or Prostate CancerCompletedNCT02206334Phase 1
- FBnTP Imaging of Breast CancerTerminatedNCT02204462Phase 1
- Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine TherapyActive, not recruitingNCT02204098Phase 1
- Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast CancerCompletedNCT02199418Phase 2
- Study of Cardiac MRI in Patients With Left-Sided Breast Cancer Receiving Radiation TherapyCompletedNCT02199366
- Preoperative and Intraoperative Quantification of Axillary Tumoral LoadTerminatedNCT02197949
- Non Invasive Detection of Lung and Breast Cancer by Odor SignatureStatus unknownNCT02195076
- Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family MembersActive, not recruitingNCT02194387Not applicable
- A Study to Investigate the Tolerability of Subcutaneous (SC) Trastuzumab Administration in Participants With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Early Breast Cancer (eBC) Using Either a Single-Use Injection Device or Manual AdministrationCompletedNCT02194166Phase 3
- Survivorship Care in Reducing Symptoms in Young Adult Cancer SurvivorsCompletedNCT02192333Not applicable
- Homeopathic Protocol for Advanced Breast CancerWithdrawnNCT02190539Not applicable
- RNA Disruption Assay (RDA) Response Prediction in Neoadjuvant Chemotherapy Breast Cancer TreatmentCompletedNCT02190227Phase 2
- Improving Adherence to Recommended Surveillance in Breast Cancer SurvivorsCompletedNCT02189278Not applicable
- Gemcitabine as a Single Agent in the Maintenance Chemotherapy of Patients With Metastatic Breast CancerStatus unknownNCT02188693
- Ambulatory SNP Under Local Anaesthesia in a Subgroup of Breast Cancer Patients - TrialStatus unknownNCT02187718Not applicable
- Studying if Adding Night Compression to Standard Care Will Have Improved Control of Lymphedema in Breast Cancer SubjectsCompletedNCT02187289Not applicable
- Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast CancerCompletedNCT02186470Not applicable
- Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain MetastasesStatus unknownNCT02185352Phase 2
- Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Metastatic Triple-negative Breast CancerTerminatedNCT02183805Phase 2
- Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-TrialCompletedNCT02181101Phase 3
- Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC PatientsStatus unknownNCT02175446Phase 2
- Clinical Application of Near-infrared Fluorescence Guided Localization on Breast Surgery in Benign Breast Neoplasm.CompletedNCT02172989
- Post-Treatment Surveillance in Breast Cancer: Bringing CER to the AllianceCompletedNCT02171078
- Clinical Application of Dual Sentinel Lymph Node Staining Method in Breast CancerCompletedNCT02168452
- KeraStat Skin Therapy in Treating Radiation Dermatitis in Patients With Newly Diagnosed Stage 0-IIIA Breast CancerWithdrawnNCT02168179Not applicable
- The Impact of a Physical Activity Program on Biomarkers of Aging During Chemotherapy for Breast CancerCompletedNCT02167932
- Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast CancerCompletedNCT02167854Phase 1
- Sentinel Node Vs Observation After Axillary Ultra-souNDActive, not recruitingNCT02167490Not applicable
- Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer SurvivorsWithdrawnNCT02166983Not applicable
- Impact of Adjuvant Treatment With Aromatase Inhibitor on Sleep Disturbances in Postmenopausal Women With Endocrine Responsive Early Breast CancerStatus unknownNCT02166281